litlas
ログインアカウント作成

John H. Sampson

1996–2025 年に発表

155
論文数
31,511
被引用数
101
h 指数
153
i10 指数

被引用数

John H. Sampson の年別被引用数1979 年: 被引用 1 件1986 年: 被引用 1 件1997 年: 被引用 4 件1998 年: 被引用 4 件1999 年: 被引用 9 件2000 年: 被引用 16 件2001 年: 被引用 23 件2002 年: 被引用 30 件2003 年: 被引用 69 件2004 年: 被引用 67 件2005 年: 被引用 71 件2006 年: 被引用 146 件2007 年: 被引用 151 件2008 年: 被引用 198 件2009 年: 被引用 256 件2010 年: 被引用 271 件2011 年: 被引用 227 件2012 年: 被引用 273 件2013 年: 被引用 251 件2014 年: 被引用 321 件2015 年: 被引用 301 件2016 年: 被引用 249 件2017 年: 被引用 403 件2018 年: 被引用 344 件2019 年: 被引用 957 件2020 年: 被引用 1,434 件2021 年: 被引用 1,533 件2022 年: 被引用 1,264 件2023 年: 被引用 1,025 件2024 年: 被引用 1,490 件2025 年: 被引用 681 件2026 年: 被引用 14 件1980〜1985 年は被引用が無いため表示していません1987〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,539 件、この内訳の 32%中国: 引用元論文 1,422 件、この内訳の 12.9%ドイツ: 引用元論文 680 件、この内訳の 6.2%イギリス: 引用元論文 501 件、この内訳の 4.5%イタリア: 引用元論文 473 件、この内訳の 4.3%フランス: 引用元論文 345 件、この内訳の 3.1%カナダ: 引用元論文 322 件、この内訳の 2.9%スイス: 引用元論文 316 件、この内訳の 2.9%オランダ: 引用元論文 314 件、この内訳の 2.8%オーストラリア: 引用元論文 252 件、この内訳の 2.3%スペイン: 引用元論文 234 件、この内訳の 2.1%日本: 引用元論文 205 件、この内訳の 1.9%
0%32%その他 22.1%

機関

分野

  • Medicine57.5%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Immunology and Microbiology12.1%
  • Neuroscience3.3%
  • Engineering2.8%
  • Materials Science2.4%
  • その他1.5%

トピック

  • Glioma Diagnosis and Treatment13.5%
  • Cancer Immunotherapy and Biomarkers4.7%
  • Immunotherapy and Immune Responses4.7%
  • CAR-T cell therapy research4.6%
  • Brain Metastases and Treatment4.3%
  • Immune cells in cancer3.4%
  • その他64.8%

共著者

全論文

検索で開く
  1. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

    著者: David A. Reardon, Alba A. Brandes, Antonio Omuro, Paul Mulholland, Michael Lim, Antje Wick, Joachim M. Baehring, Manmeet S. Ahluwalia, Patrick Roth, Oliver Bähr, Surasak Phuphanich, Juan Manuel Sepúlveda-Sánchez, Paul de Souza, Solmaz Sahebjam, Michael Carleton, Kay Tatsuoka, Corina Taitt, Ricardo Zwirtes, John H. Sampson, Michael Weller - JAMA Oncology 2020 被引用: 1,457

  2. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

    著者: Michael Weller, Nicholas Butowski, David Tran, Lawrence D. Recht, Michael Lim, Hal W. Hirte, Lynn S. Ashby, Laszlo Mechtler, Samuel Goldlust, Fábio M. Iwamoto, Jan Drappatz, Donald M. O’Rourke, Mark Wong, Mark G. Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, Christopher D. Turner, Michael Yellin, Tibor Keler, Thomas A. Davis, Roger Stupp, John H. Sampson, Nicholas Butowski, Jian Campian, Lawrence D. Recht, Michael Lim, Lynn S. Ashby, Jan Drappatz, Hal W. Hirte, Fábio M. Iwamoto, Laszlo Mechtler, Samuel Goldlust, Kevin Becker, Gene H. Barnett, Garth Nicholas, Annick Desjardins, Tara Benkers, Naveed Wagle, Morris D. Groves, Santosh Kesari, Zsolt Horváth, Ryan Merrell, Richard Curry, James O’Rourke, David M. Schuster, Mark Wong, Maciej M. Mrugała, Randy Jensen, John Trusheim, Glenn J. Lesser, Karl Bélanger, Andrew E. Sloan, Benjamin Purow, Karen Fink, Jeffrey J. Raizer, Michael Schulder, Suresh Nair, Scott Peak, James Perry, Alba A. Brandes, Michael Weller, Nimish Mohile, Joseph Landolfi, Jon Olson, Gaetano Finocchiaro, Ross Jennens, Paul DeSouza, Bridget A. Robinson, Marka R. Crittenden, Kent C. Shih, Alexandra Flowers, Shirley Ong, Jennifer Connelly, Costas G. Hadjipanayis, Pierre Giglio, Frank E. Mott, David Mathieu, N. Lessard, Sanchez Juan Sepulveda, József Lövey, Helen Wheeler, Po-Ling Inglis, Claire Hardie, Daniela A. Bota, Maciej S. Lesniak, Jana Portnow, Bruce Frankel, Larry Junck, Reid C. Thompson, Lawrence Berk, John Paul McGhie, David Macdonald, Frank Saran, Riccardo Soffietti, Deborah T. Blumenthal, Sá Barreto Costa Marcos André de, Anna K. Nowak ほか 93 名 - The Lancet Oncology 2017 被引用: 1,113

  3. Brain immunology and immunotherapy in brain tumours

    著者: John H. Sampson, Michael D. Gunn, Peter E. Fecci, David M. Ashley - Nature reviews. Cancer 2019 被引用: 725

  4. Challenges to curing primary brain tumours

    著者: Kenneth Aldape, Kevin M. Brindle, Louis Chesler, Rajesh Chopra, Amar Gajjar, Mark R. Gilbert, Nicholas G. Gottardo, David H. Gutmann, Darren Hargrave, Eric C. Holland, David Jones, Johanna A. Joyce, Pamela Kearns, Mark W. Kieran, Ingo K. Mellinghoff, Melinda S. Merchant, Stefan M. Pfister, Steven M. Pollard, Vijay Ramaswamy, Jeremy N. Rich, Giles Robinson, David H. Rowitch, John H. Sampson, Michael D. Taylor, Paul Workman, Richard J. Gilbertson - Nature Reviews Clinical Oncology 2019 被引用: 972

  5. Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

    著者: Pakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, Franziska Loebel, Xiuyu Cui, S. Harrison Farber, Karolina Woroniecka, Aladine A. Elsamadicy, Cosette Dechant, Hanna Kemeny, Luis Sánchez-Pérez, Tooba A. Cheema, Nicholas Souders, James E. Herndon, Jean-Valéry Coumans, Jeffrey I. Everitt, Brian V. Nahed, John H. Sampson, Michael D. Gunn, Robert L. Martuza, Glenn Dranoff, William T. Curry, Peter E. Fecci - Nature Medicine 2018 被引用: 664

  6. Recurrent Glioblastoma Treated with Recombinant Poliovirus

    著者: Annick Desjardins, Matthias Gromeier, James E. Herndon, Nike Beaubier, Dani P. Bolognesi, Allan H. Friedman, Henry S. Friedman, Frances McSherry, Andrea Muscat, Smita K. Nair, Katherine B. Peters, Dina Randazzo, John H. Sampson, Gordana Vlahovic, W.T.A. Harrison, Roger E. McLendon, David M. Ashley, Darell D. Bigner - New England Journal of Medicine 2018 被引用: 802

  7. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

    著者: Hideho Okada, Michael Weller, Raymond Y. Huang, Gaetano Finocchiaro, Mark R. Gilbert, Wolfgang Wick, Benjamin M. Ellingson, Naoya Hashimoto, Ian F. Pollack, Alba A. Brandes, Enrico Franceschi, Christel Herold‐Mende, Lakshmi Nayak, Ashok Panigrahy, Whitney B. Pope, Robert M. Prins, John H. Sampson, Patrick Y. Wen, David A. Reardon - The Lancet Oncology 2015 被引用: 763

  8. Brain Tumor Microenvironment and Host State: Implications for Immunotherapy

    著者: William H. Tomaszewski, Luis Sánchez-Pérez, Thomas F. Gajewski, John H. Sampson - Clinical Cancer Research 2019 被引用: 324

  9. CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis

    著者: Emily Lerner, Karolina Woroniecka, Vincent M. D’Anniballe, Daniel Wilkinson, Aditya Mohan, Selena Lorrey, Jessica Waibl Polania, Lucas P. Wachsmuth, Alexandra Miggelbrink, Joshua Jackson, Xiuyu Cui, Jude Raj, William H. Tomaszewski, Sarah Cook, John H. Sampson, Anoop P. Patel, Mustafa Khasraw, Michael D. Gunn, Peter E. Fecci - Nature Cancer 2023 被引用: 138

  10. Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143

    著者: Antonio Omuro, Gordana Vlahovic, Michael Lim, Solmaz Sahebjam, Joachim M. Baehring, Timothy F. Cloughesy, Alfredo Voloschin, Shakti Ramkissoon, Keith L. Ligon, Robert Latek, Ricardo Zwirtes, Lewis C. Strauss, Prashni Paliwal, Christopher Harbison, David A. Reardon, John H. Sampson - Neuro-Oncology 2017 被引用: 488

  11. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

    著者: Duane A. Mitchell, Kristen A. Batich, Michael D. Gunn, Min-Nung Huang, Luis Sánchez-Pérez, Smita K. Nair, Kendra L. Congdon, Elizabeth A. Reap, Gary E. Archer, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, James E. Herndon, April Coan, Roger E. McLendon, David A. Reardon, James J. Vredenburgh, Darell D. Bigner, John H. Sampson - Nature 2015 被引用: 524

  12. Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma

    著者: Peter E. Fecci, Duane A. Mitchell, John F. Whitesides, Weihua Xie, Allan H. Friedman, Gary E. Archer, James E. Herndon, Darell D. Bigner, Glenn Dranoff, John H. Sampson - Cancer Research 2006 被引用: 620

  13. Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement

    著者: Stephen Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Burt Nabors, Manmeet S. Ahluwalia, Roger Stupp, Minesh P. Mehta, David A. Reardon, Stuart A. Grossman, Erik P. Sulman, John H. Sampson, Simon Khagi, Michael Weller, Timothy F. Cloughesy, Patrick Y. Wen, Mustafa Khasraw - Clinical Cancer Research 2021 被引用: 164

  14. Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

    著者: Kristen A. Batich, Elizabeth A. Reap, Gary E. Archer, Luis Sánchez-Pérez, Smita K. Nair, Robert J. Schmittling, Pam Norberg, Weihua Xie, James E. Herndon, Patrick Healy, Roger E. McLendon, Allan H. Friedman, Henry S. Friedman, Darell D. Bigner, Gordana Vlahovic, Duane A. Mitchell, John H. Sampson - Clinical Cancer Research 2017 被引用: 288

  15. Oncolytic virus-derived type I interferon restricts CAR T cell therapy

    著者: Laura Evgin, Amanda L. Huff, Phonphimon Wongthida, Jill Thompson, Tim Kottke, Jason M. Tonne, Matthew Schuelke, Katayoun Ayasoufi, Christopher B. Driscoll, Kevin G. Shim, Pierce Reynolds, Dileep D. Monie, Aaron J. Johnson, Matt Coffey, Sarah L. Young, Gary E. Archer, John H. Sampson, José S. Pulido, Luis Sanchez Perez, Richard G. Vile - Nature Communications 2020 被引用: 118

  16. Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

    著者: John H. Sampson, Amy B. Heimberger, Gary E. Archer, Kenneth Aldape, Allan H. Friedman, Henry S. Friedman, Mark R. Gilbert, James E. Herndon, Roger E. McLendon, Duane A. Mitchell, David A. Reardon, Raymond Sawaya, Robert J. Schmittling, Weiming Shi, James J. Vredenburgh, Darell D. Bigner - Journal of Clinical Oncology 2010 被引用: 808

  17. Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

    著者: David A. Reardon, Annick Desjardins, James J. Vredenburgh, Donald M. O’Rourke, David Tran, Karen Fink, Burt Nabors, Gordon Li, Daniela A. Bota, Rimas V. Lukas, Lynn S. Ashby, J. Paul Duic, Maciej M. Mrugała, Scott Cruickshank, Laura Vitale, Yi He, Jennifer A. Green, Michael Yellin, Christopher D. Turner, Tibor Keler, Thomas A. Davis, John H. Sampson - Clinical Cancer Research 2020 被引用: 177

  18. A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

    著者: James M. Schuster, R. K. Lai, Lawrence D. Recht, David A. Reardon, Nina A. Paleologos, Morris D. Groves, Maciej M. Mrugała, Randy L. Jensen, Joachim M. Baehring, Andrew E. Sloan, Gerald E. Archer, D. D. Bigner, Scott Cruickshank, J. A. Green, Tibor Keler, Thomas A. Davis, Amy B. Heimberger, John H. Sampson - Neuro-Oncology 2015 被引用: 417

  19. Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

    著者: John H. Sampson, Kenneth Aldape, Gerald E. Archer, April Coan, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, Mark R. Gilbert, James E. Herndon, Roger E. McLendon, Duane A. Mitchell, David A. Reardon, Raymond Sawaya, Robert J. Schmittling, Weiming Shi, James J. Vredenburgh, Darell D. Bigner, Amy B. Heimberger - Neuro-Oncology 2010 被引用: 369

  20. Proteomic and immunologic analyses of brain tumor exosomes

    著者: Michael W. Graner, Óscar Álzate, Angelika M. Dechkovskaia, Jack D. Keene, John H. Sampson, Duane A. Mitchell, Darell D. Bigner - The FASEB Journal 2008 被引用: 427

  21. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

    著者: Sushma Kunwar, Susan M. Chang, Manfred Westphal, Michael A. Vogelbaum, John H. Sampson, Gene H. Barnett, Mark E. Shaffrey, Zvi Ram, J Piepmeier, Michael D. Prados, David Croteau, Christoph Pedain, Pamela Leland, Syed R. Husain, Bharat Joshi, Raj K. Puri, for the PRECISE Study Group - Neuro-Oncology 2010 被引用: 481

  22. Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

    著者: Matthias Gromeier, Michael C. Brown, Gao Zhang, Xiang Lin, Yeqing Chen, Zhi Wei, Nike Beaubier, Hai Yan, Yiping He, Annick Desjardins, James E. Herndon, Frederick S. Varn, Roel G.W. Verhaak, Junfei Zhao, Dani P. Bolognesi, Allan H. Friedman, Henry S. Friedman, Frances McSherry, Andrea Muscat, Eric Lipp, Smita K. Nair, Mustafa Khasraw, Katherine B. Peters, Dina Randazzo, John H. Sampson, Roger E. McLendon, Darell D. Bigner, David M. Ashley - Nature Communications 2021 被引用: 124

  23. Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3

    著者: Teilo Schaller, Kristen A. Batich, Carter M. Suryadevara, Rupen Desai, John H. Sampson - Expert Review of Clinical Immunology 2017 被引用: 148

  24. EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss

    著者: John H. Sampson, Bryan D. Choi, Luis Sánchez-Pérez, Carter M. Suryadevara, David J. Snyder, Catherine Flores, Robert J. Schmittling, Smita K. Nair, Elizabeth A. Reap, Pamela K. Norberg, James E. Herndon, Chien-Tsun Kuan, Richard A. Morgan, Steven A. Rosenberg, Laura A. Johnson - Clinical Cancer Research 2013 被引用: 293